Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
01 1NURAY CHEMICALS PRIVATE LIMITED
01 1Methsuximide
01 1India
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
NDC Package Code : 58159-063
Start Marketing Date : 2020-06-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
A Methsuximide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methsuximide, including repackagers and relabelers. The FDA regulates Methsuximide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methsuximide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methsuximide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methsuximide supplier is an individual or a company that provides Methsuximide active pharmaceutical ingredient (API) or Methsuximide finished formulations upon request. The Methsuximide suppliers may include Methsuximide API manufacturers, exporters, distributors and traders.
click here to find a list of Methsuximide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methsuximide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methsuximide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methsuximide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methsuximide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methsuximide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methsuximide suppliers with NDC on PharmaCompass.
We have 1 companies offering Methsuximide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
